{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:33:45Z","timestamp":1774053225501,"version":"3.50.1"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["Paris-Descartes university"],"award-info":[{"award-number":["Paris-Descartes university"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["Sorbonne University"],"award-info":[{"award-number":["Sorbonne University"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2019.00136","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T12:10:50Z","timestamp":1561637450000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Kallikrein\/K1, Kinins, and ACE\/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication"],"prefix":"10.3389","volume":"6","author":[{"given":"Francois","family":"Alhenc-Gelas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Bouby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Girolami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,27]]},"reference":[{"key":"B1","first-page":"511","article-title":"Les substances hypotensives de l'urine humaine normale","volume":"66","author":"Abelous","year":"1909","journal-title":"CR Soc Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1515\/bchm2.1930.189.3-4.97","article-title":"Der Nachweis eines Kreislaufhormon in der Pankreasdruse","volume":"189","author":"Kraut","year":"1930","journal-title":"Hoppe-Seylers Z Physiol Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.HYP.16.4.363","article-title":"Angiotensin I converting enzyme and the changes in our concepts through the years","volume":"16","author":"Erdos","year":"1990","journal-title":"Hypertension."},{"key":"B4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1161\/01.HYP.21.2.259","article-title":"Discovery of the two angiotensin peptides and the angiotensin convertingenzyme","volume":"21","author":"Skeggs","year":"1993","journal-title":"Hypertension."},{"key":"B5","first-page":"81","article-title":"Molecular and physiological aspect of angiotensin I-converting enzyme","volume-title":"Handbook of Physiology Section 7","author":"Alhenc-Gelas","year":"2000"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1046\/j.1523-1755.1999.00660.x","article-title":"Angiotensin-converting enzyme in non-neoplastic kidney diseases","volume":"56","author":"Metzger","year":"1999","journal-title":"Kidney Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.mvr.2010.12.003","article-title":"Heterogeneous distribution of angiotensin I-converting enzyme (CD143) in the human and rat vascular systems: vessel, organ and species specificity","volume":"81","author":"Metzger","year":"2011","journal-title":"Microvasc Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/BF00537778","article-title":"The conversion of angiotensin I to angiotensin II in vivo","volume":"259","author":"Ng","year":"1968","journal-title":"Naunyn Schmiedebergs Arch Exp Pathol Pharmakol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/HJH.0b013e3282f4d1fa","article-title":"Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins exretion in man","volume":"26","author":"Azizi","year":"2008","journal-title":"J Hypertens."},{"key":"B10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/00004872-199308000-00002","article-title":"The molecular biology of the kallikrein -kinin system: II. The rat gene family","volume":"11","author":"Scicli","year":"1993","journal-title":"J Hypertens."},{"key":"B11","doi-asserted-by":"publisher","first-page":"37397","DOI":"10.1074\/jbc.M004525200","article-title":"Tissue-specific expression patterns and fine mapping of the human Kallikrein (KLK) locus on proximal 19q13","volume":"275","author":"Harvey","year":"2000","journal-title":"J Biol Chem."},{"key":"B12","first-page":"7","article-title":"Molecular and genetic aspects of the Kallikrein-kinin system","author":"Alhenc-Gelas","year":"2012","journal-title":"Kinins. De Gruyter"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1073\/pnas.051619598","article-title":"Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice","volume":"98","author":"Meneton","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/01.HYP.0000021747.43346.95","article-title":"Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice","volume":"40","author":"Trabold","year":"2002","journal-title":"Hypertension."},{"key":"B15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/01.RES.88.6.593","article-title":"Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice","volume":"88","author":"Bergaya","year":"2001","journal-title":"Circ Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1172\/JCI23669","article-title":"Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans","volume":"115","author":"Azizi","year":"2005","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/01.ATV.0000090672.07568.60","article-title":"Uterine artery structural and functional changes during pregnancy in tissue kallikrein-deficient mice","volume":"23","author":"Hilgers","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1161\/01.RES.0000131497.73744.1a","article-title":"Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors","volume":"94","author":"Bergaya","year":"2004","journal-title":"Circ Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/01.HYP.35.1.155","article-title":"Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function","volume":"35","author":"Carey","year":"2000","journal-title":"Hypertension."},{"key":"B20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1172\/JCI7886","article-title":"Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation","volume":"104","author":"Tsutsumi","year":"1999","journal-title":"J Clin Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"R1385","DOI":"10.1152\/ajpregu.90411.2008","article-title":"Tissue kallikrein deficiency and renovascular hypertension in the mouse","volume":"296","author":"Griol-Charhbili","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1681\/ASN.2004110923","article-title":"Tissue Kallikrein-deficient mice display a defect in renal tubular calcium absorption","volume":"16","author":"Picard","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"13526","DOI":"10.1073\/pnas.0913070107","article-title":"Tissue kallikrein permits early renal adaptation to potassium load","volume":"107","author":"El Moghrabi","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/oxfordjournals.aje.a112282","article-title":"Familial aggregationof urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes","volume":"104","author":"Zinner","year":"1976","journal-title":"Am J Epidemiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/01.HYP.13.1.3","article-title":"A gene for high urinary kallikrein may protect against hypertension in Utah kindreds","volume":"13","author":"Berry","year":"1989","journal-title":"Hypertension."},{"key":"B26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1681\/ASN.V134968","article-title":"Loss-of-function polymorphism of the human kallikrein gene with reduced urinary kallikrein activity","volume":"13","author":"Slim","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2215\/CJN.02630706","article-title":"Partial human genetic deficiency in tissue kallikrein activity and renal calcium handling","volume":"2","author":"Blanchard","year":"2007","journal-title":"Clin J Am Soc Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/ki.2013.224","article-title":"Partial genetic deficiency in tissue kallikrein impairs adaptation to high potassium intake in humans","volume":"84","author":"Monteiro","year":"2013","journal-title":"Kidney Int."},{"key":"B29","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/S0021-9258(19)67628-3","article-title":"Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes","volume":"266","author":"Wei","year":"1991","journal-title":"J Biol Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/00004872-198909007-00003","article-title":"The angiotensin converting enzyme in the kidney","volume":"7","author":"Alhenc-Gelas","year":"1989","journal-title":"J Hypertens."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1172\/JCI119419","article-title":"The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice","volume":"99","author":"Esther","year":"1997","journal-title":"J Clin Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9386","DOI":"10.1073\/pnas.85.24.9386","article-title":"Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning","volume":"85","author":"Soubrier","year":"1988","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1016\/S0021-9258(18)80158-2","article-title":"Mouse angiotensinconverting enzyme is a protein composed of two homologous domains","volume":"264","author":"Bernstein","year":"1989","journal-title":"J Biol Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0014-5793(89)80897-X","article-title":"The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme","volume":"252","author":"Lattion","year":"1989","journal-title":"FEBS Lett."},{"key":"B35","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1016\/S0021-9258(18)98378-X","article-title":"Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides","volume":"268","author":"Jaspard","year":"1993","journal-title":"J Biol Chem."},{"key":"B36","doi-asserted-by":"crossref","first-page":"26806","DOI":"10.1016\/S0021-9258(18)47091-3","article-title":"Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site","volume":"269","author":"Danilov","year":"1994","journal-title":"J Biol Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1515\/hsz-2016-0228","article-title":"Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications","volume":"397","author":"Desposito","year":"2016","journal-title":"Biol Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1111\/j.1538-7836.2007.02770.x","article-title":"The plasma kallikrein -kinin system: its evolution from contact activation","volume":"5","author":"Schmaier","year":"2007","journal-title":"J Thromb Haemost."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1210\/en.2002-221045","article-title":"Minireview: computer simulations of blood pressure regulation by the renin -angiotensin system","volume":"144","author":"Takahashi","year":"2003","journal-title":"Endocrinology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/01.HYP.23.4.439","article-title":"Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides","volume":"23","author":"Campbell","year":"1994","journal-title":"Hypertension."},{"key":"B41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/01.hjh.0000166834.32817.41","article-title":"Angiotensinogen and angiotensin-converting enzyme gene copy number and angiotensin and bradykinin peptide levels in mice","volume":"23","author":"Alexiou","year":"2005","journal-title":"J Hypertens."},{"key":"B42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000123512","article-title":"Angiotensin-converting enzyme in epithelial and neuroepithelial cells","volume":"37","author":"Defendini","year":"1983","journal-title":"Neuroendocrinology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1172\/JCI118484","article-title":"Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline","volume":"97","author":"Azizi","year":"1996","journal-title":"J Clin Invest."},{"key":"B44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/01.HYP.0000107777.91185.89","article-title":"Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction","volume":"43","author":"Yang","year":"2004","journal-title":"Hypertension."},{"key":"B45","doi-asserted-by":"publisher","first-page":"47863","DOI":"10.1074\/jbc.M104068200","article-title":"Angiotensin-converting enzyme degrades Alzheimer amyloid A\u03b2-peptide (A\u03b2); retards A\u03b2 aggregation, deposition, fibril formation; and inhibits cytotoxicity","volume":"276","author":"Hu","year":"2001","journal-title":"J Biol Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"37644","DOI":"10.1074\/jbc.M508460200","article-title":"Amyloid \u03b2-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor","volume":"280","author":"Hemming","year":"2005","journal-title":"J Biol Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1172\/JCI66541","article-title":"Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline","volume":"124","author":"Bernstein","year":"2014","journal-title":"J Clin Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/aje\/kwi202","article-title":"Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease","volume":"162","author":"Lehmann","year":"2005","journal-title":"Am J Epidemiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.RES.0000217340.40936.53","article-title":"Signaling by the angiotensin-converting enzyme","volume":"98","author":"Fleming","year":"2006","journal-title":"Circ Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1124\/mol.105.020636","article-title":"Angiotensin-converting enzyme (ACE) dimerization is the initial step in the ACE inhibitor-induced ACE signaling cascade in endothelial cells","volume":"69","author":"Kohlstedt","year":"2006","journal-title":"Mol Pharmacol."},{"key":"B51","first-page":"1180","article-title":"Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia","volume":"284","author":"Costerousse","year":"1998","journal-title":"J Pharmacol Exp Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/HYPERTENSIONAHA.110.167171","article-title":"Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling","volume":"57","author":"Guimar\u00e3es","year":"2011","journal-title":"Hypertension."},{"key":"B53","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1160\/TH12-12-0937","article-title":"Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man","volume":"110","author":"Waeckel","year":"2013","journal-title":"Thromb Haemost."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/ki.2008.647","article-title":"The kallikrein-kinin system in health and in diseases of the kidney","volume":"75","author":"Kakoki","year":"2009","journal-title":"Kidney Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1096\/fj.04-3508fje","article-title":"Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia","volume":"19","author":"Griol-Charhbili","year":"2005","journal-title":"FASEB J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1096\/fj.10-165902","article-title":"Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia","volume":"24","author":"Messadi","year":"2010","journal-title":"FASEB J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1124\/jpet.107.124859","article-title":"Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia","volume":"323","author":"Messadi-Laribi","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bcp.2015.01.007","article-title":"Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouse","volume":"94","author":"Youcef","year":"2015","journal-title":"Biochem Pharmacol."},{"key":"B59","first-page":"25","article-title":"Contribution of kininsto the cardiovascular actions of angiotensin-converting enzyme inhibitors","volume":"47","author":"Linz","year":"1995","journal-title":"Pharmacol Rev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/hh1001.090759","article-title":"Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice","volume":"88","author":"Yang","year":"2001","journal-title":"Circ Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/01.HYP.29.1.150","article-title":"Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis","volume":"29","author":"Krege","year":"1997","journal-title":"Hypertension."},{"key":"B62","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1161\/01.HYP.30.3.735","article-title":"Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia\/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats","volume":"30","author":"Yang","year":"1997","journal-title":"Hypertension."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1161\/01.CIR.102.18.2190","article-title":"Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway","volume":"102","author":"Brown","year":"2000","journal-title":"Circulation."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1096\/fasebj.3.9.2545495","article-title":"Endothelium-derived relaxing and contracting factors","volume":"3","author":"Furchgott","year":"1989","journal-title":"FASEB J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/01.RES.78.3.415","article-title":"Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors","volume":"78","author":"Campbell","year":"1996","journal-title":"Circ Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/46816","article-title":"Cytochrome P450 2C is an EDHF synthase in coronary arteries","volume":"401","author":"Fisslthaler","year":"1999","journal-title":"Nature."},{"key":"B67","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MNH.0b013e32834d54b1","article-title":"The kallikrein-kinin system and oxidative stress","volume":"21","author":"Kayashima","year":"2012","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"B68","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/ATVBAHA.108.182139","article-title":"Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization","volume":"29","author":"Stone","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/hh2001.097691","article-title":"Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway","volume":"89","author":"Silvestre","year":"2001","journal-title":"Circ Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCRESAHA.111.240986","article-title":"Arteriogenesis is modulated by bradykinin receptor signaling","volume":"109","author":"Hillmeister","year":"2011","journal-title":"Circ Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1161\/CIRCRESAHA.108.179952","article-title":"Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential","volume":"103","author":"Krankel","year":"2008","journal-title":"Circ Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1161\/CIRCRESAHA.110.236786","article-title":"Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells","volume":"108","author":"Spinetti","year":"2011","journal-title":"Circ Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1124\/jpet.114.219196","article-title":"Kinin receptor agonism restores hindlimb post-ischemic neovascularization capacity in diabetic mice","volume":"352","author":"Desposito","year":"2015","journal-title":"J Pharmacol Exp Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"H507","DOI":"10.1152\/ajpheart.2000.278.2.H507","article-title":"Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats","volume":"278","author":"Liu","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejheart.2008.02.002","article-title":"Tissue kallikrein deficiency aggravates cardiac remodeling and decreases survival after myocardial infarction in mice","volume":"10","author":"Pons","year":"2008","journal-title":"Eur J Heart Fail."},{"key":"B76","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1161\/HYPERTENSIONAHA.113.02902","article-title":"Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism","volume":"63","author":"Koid","year":"2014","journal-title":"Hypertension."},{"key":"B77","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ki.2009.208","article-title":"Kallikrein protects against microalbuminuria in experimental type I diabetes","volume":"76","author":"Bodin","year":"2009","journal-title":"Kidney Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"13330","DOI":"10.1073\/pnas.231476798","article-title":"Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse","volume":"98","author":"Huang","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B79","doi-asserted-by":"publisher","first-page":"13302","DOI":"10.1073\/pnas.0405449101","article-title":"Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor","volume":"101","author":"Kakoki","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1172\/JCI26958","article-title":"Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors","volume":"116","author":"Kakoki","year":"2006","journal-title":"J Clin Invest."},{"key":"B81","doi-asserted-by":"publisher","first-page":"H350","DOI":"10.1152\/ajpheart.00356.2017","article-title":"Genetically increased angiotensin I-converting enzyme alters peripheral and renal vascular reactivity to angiotensin II and bradykinin in mice","volume":"314","author":"Chollet","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B82","first-page":"125","article-title":"Urinary kallikrein excretion in hypertension","volume":"31","author":"Margolius","year":"1972","journal-title":"Circ Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1210\/en.2012-1225","article-title":"Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse","volume":"153","author":"Waeckel","year":"2012","journal-title":"Endocrinology."},{"key":"B84","first-page":"774","article-title":"Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study","volume":"43","author":"Cambien","year":"1988","journal-title":"Am J Hum Genet."},{"key":"B85","first-page":"33","article-title":"Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters","volume":"117","author":"Alhenc-Gelas","year":"1991","journal-title":"J Lab Clin Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J Clin Invest."},{"key":"B87","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/bj2900033","article-title":"Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes","volume":"290","author":"Costerousse","year":"1993","journal-title":"Biochem J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/01.CIR.92.6.1387","article-title":"Angiotensin-converting enzyme in the human heart. Effect of the deletion\/insertion polymorphism","volume":"92","author":"Danser","year":"1995","journal-title":"Circulation."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/hmg\/7.11.1745","article-title":"Measured haplotype analysis of the angiotensin-I converting enzyme gene","volume":"7","author":"Keavney","year":"1998","journal-title":"Hum Mol Genet."},{"key":"B90","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/359641a0","article-title":"Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction","volume":"359","author":"Cambien","year":"1992","journal-title":"Nature."},{"key":"B91","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/01.CIR.90.2.669","article-title":"Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction","volume":"90","author":"Cambien","year":"1994","journal-title":"Circulation."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/01.RES.0000223145.74217.e7","article-title":"ACE polymorphisms","volume":"98","author":"Sayed-Tabatabaei","year":"2006","journal-title":"Circ Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2337\/diabetes.43.3.384","article-title":"Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications","volume":"43","author":"Marre","year":"1994","journal-title":"Diabetes."},{"key":"B94","doi-asserted-by":"publisher","first-page":"690","DOI":"10.2337\/diab.43.5.690","article-title":"Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I\u2013converting enzyme gene","volume":"43","author":"Doria","year":"1994","journal-title":"Diabetes."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1172\/JCI119321","article-title":"Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group","volume":"99","author":"Marre","year":"1997","journal-title":"J Clin Invest."},{"key":"B96","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/bmj.313.7057.591","article-title":"Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study","volume":"313","author":"Parving","year":"1996","journal-title":"BMJ."},{"key":"B97","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1681\/ASN.V123541","article-title":"Prognostic value of angiotensin-I converting enzyme I\/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study","volume":"12","author":"Hadjadj","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.2337\/diabetes.54.4.1238","article-title":"Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy: the DCCT\/EDIC genetics study","volume":"54","author":"Boright","year":"2005","journal-title":"Diabetes."},{"key":"B99","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/aje\/kwj287","article-title":"Identifying genetic susceptibilities to diabetes-related complications among individuals at low risk of complications: an application of tree-structured survival analysis","volume":"164","author":"Costacou","year":"2006","journal-title":"Am J Epidemiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1681\/ASN.2006101102","article-title":"Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations","volume":"18","author":"Hadjadj","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJM198905043201801","article-title":"Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy","volume":"320","author":"Seaquist","year":"1989","journal-title":"N Engl J Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/01.CIR.102.8.829","article-title":"Angiotensin-converting enzyme insertion\/deletion polymorphism modulates the human in vivo metabolism of bradykinin","volume":"102","author":"Murphey","year":"2000","journal-title":"Circulation."},{"key":"B104","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/01.HYP.33.3.775","article-title":"Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes","volume":"33","author":"Marre","year":"1999","journal-title":"Hypertension."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.2174\/138161211797416002","article-title":"Kinins as therapeutic agents in cardiovascular and renal diseases","volume":"17","author":"Alhenc-Gelas","year":"2011","journal-title":"Curr Pharm Des."},{"key":"B106","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/01.CIR.103.1.125","article-title":"Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia","volume":"103","author":"Emanueli","year":"2001","journal-title":"Circulation."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1096\/fj.99-1011fje","article-title":"Increased kallikrein expression protects against cardiac ischemia","volume":"14","author":"Pinto","year":"2000","journal-title":"FASEB J."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1096\/fj.99-1010fje","article-title":"Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene","volume":"14","author":"Silva","year":"2000","journal-title":"FASEB J."},{"key":"B109","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1096\/fj.03-0736com","article-title":"Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene","volume":"18","author":"Tsch\u00f6pe","year":"2004","journal-title":"FASEB J."},{"key":"B110","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejphar.2006.08.054","article-title":"Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction","volume":"550","author":"Koch","year":"2006","journal-title":"Eur J Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0304-4165(81)90262-2","article-title":"Measurement of urinary kallikrein activity. Species differences in kinin production","volume":"677","author":"Alhenc-Gelas","year":"1981","journal-title":"Biochim Biophys Acta."},{"key":"B112","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.peptides.2008.12.003","article-title":"Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor","volume":"30","author":"Belanger","year":"2009","journal-title":"Peptides."},{"key":"B113","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.peptides.2008.12.018","article-title":"Novel kinin B1 receptor agonists with improved pharmacological profiles","volume":"30","author":"Cote","year":"2009","journal-title":"Peptides."},{"key":"B114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1124\/jpet.113.203927","article-title":"Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes","volume":"346","author":"Potier","year":"2013","journal-title":"J Pharmacol Exp Ther."},{"key":"B115","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1515\/BC.2001.005","article-title":"Classification of kinin receptors","volume":"382","author":"Regoli","year":"2001","journal-title":"Biol Chem."},{"key":"B116","doi-asserted-by":"publisher","first-page":"9410","DOI":"10.1038\/s41598-017-09721-0","article-title":"Neuroprotective effect of kinin B1 receptor activation in acute cerebral ischemia in diabetic mice","volume":"7","author":"Desposito","year":"2017","journal-title":"Sci Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/CS20150295","article-title":"Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade","volume":"130","author":"Desposito","year":"2016","journal-title":"Clin Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/hc0502.102965","article-title":"Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment","volume":"105","author":"Marin-Casta\u00f1o","year":"2002","journal-title":"Circulation."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ki.2008.9","article-title":"The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney","volume":"73","author":"Phipps","year":"2008","journal-title":"Kidney Int."},{"key":"B120","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-3-319-06683-7_5","article-title":"The kallikrein-kinin system in diabetic retinopathy","volume":"69","author":"Bhat","year":"2014","journal-title":"Prog Drug Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1056\/NEJMx100067","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/BF00165756","article-title":"The effect of kinin agonists and antagonists on the pain response of the human blister base","volume":"336","author":"Whalley","year":"1987","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"k4209","DOI":"10.1136\/bmj.k4209","article-title":"Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study","volume":"363","author":"Hicks","year":"2018","journal-title":"BMJ."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00136\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T03:32:03Z","timestamp":1663817523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00136\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,27]]},"references-count":123,"alternative-id":["10.3389\/fmed.2019.00136"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2019.00136","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,27]]},"article-number":"136"}}